Compound Information | |
---|---|
ID | 90 |
TrivialName | Ginsenoside Rk3 |
Type | PPD |
MF | C₃₆H₆₀O₈ |
MolecularWeight | 620.868 |
IUPACName | (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
m/z | 665.4273 |
Retention Time | 46.17 |
CCS | 276.72 |
Adducts | [M−H+HCOOH]− |
Isomeric SMILES | O[C@H]1CC[C@@]2(C)[C@]([C@@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O3)C[C@]4(C)[C@]2([H])C[C@@H](O)[C@@]5([H])[C@@]4(C)CC[C@]5([H])C(CC/C=C(C)/C)=C)([H])C1(C)C |
Canonical SMILES | C=C(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3O)CC12C |
Source | Other |
Functions | Anti-diabetic, anti-inflammatory, anti-oxidant, nueroprotective agent, anti-cancer, treatment for Alzheimer's disease, treatment for Ulcerative Colitis, |
Year | 2002 |
References | |
Structure |
|